| Modicon Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Modicon 35 mcg-0.5 mg | tablet | oral | 1.0 each | OTC |
| Modicon 35 mcg-0.5 mg | tablet | oral | 1.0 each | OTC |
Posted by gcheifort50 over 7 years ago
I've been on Necon 1/35 28 BC for at least 5 years, I would like a lower dose if possible, the pharmacist advised Modicon .5/35 28. Is this a definitely lower dose. I'm 51 yrs of age. Also I would like some side effects sent to me for the Modicon BC
Industrial Maintenance Mechanic - Seattle Times
The plant also has a variety of electrical equipment including, Allen Bradley PLC's & VFD's, Danfoss drives, Modicon PLC's and Ethernet communications. ...
Fri Mar 07 18:33:46 +0000 2008
Manage remote assets using 'open' technologies - Processing Talk
... supports all the major PLC manufacturers, including Allen-Bradley, Siemens, Schneider, Telemecanique, Wonderware, Rockwell, GE, Indramat and Modicon. ...
Tue Feb 26 21:25:01 +0000 2008
Modicon: always original, always the best! - Voltimum (subscription)
This challenge led directly to the development of the programmable Modular Digital Controller, or Modicon. In all but name, this was the world’s first PLC ...
Mon Feb 25 06:20:51 +0000 2008
ethinyl estradiol - A semisynthetic estrogen. Ethinyl estradiol binds to the estrogen receptor complex and enters the nucleus, activating DNA transcription of genes involved in estrogenic cellular responses. This agent also inhibits 5-alpha reductase in epididymal tissue, which lowers testosterone levels and may delay progression of prostatic cancer. In addition to its antineoplastic effects, ethinyl estradiol protects against osteoporosis. In animal models, short-term therapy with this agent has been shown to provide long-term protection against breast cancer, mimicking the antitumor effects of pregnancy. (NCI04)
norethindrone - The acetate salt form of norethindrone, a synthetic progestational substance with some anabolic, estrogenic, and androgenic properties. Norethindrone binds to the progesterone intracellular receptors in the reproductive system and the resultant activated complex interacts with specific DNA sites. This leads to an alteration in protein synthesis and results in an inhibition of LH release. Consequently, it inhibits ovulation and changes the normal cycle of cervical mucus and endometrium.